Klebanoff S J, Waltersdorph A M
Department of Medicine, University of Washington, Seattle 98195.
Arch Biochem Biophys. 1988 Aug 1;264(2):600-6. doi: 10.1016/0003-9861(88)90326-8.
Phagocytes generate superoxide (O2-.) and hydrogen peroxide (H2O2) and their interaction in an iron-catalyzed reaction to form hydroxyl radicals (OH.) (Haber-Weiss reaction) has been proposed. Deferoxamine chelates iron in a catalytically inactive form, and thus inhibition by deferoxamine has been employed as evidence for the involvement of OH. generated by the Haber-Weiss reaction. We report here that deferoxamine also inhibits reactions catalyzed by the peroxidases of phagocytes, i.e., myeloperoxidase (MPO) and eosinophil peroxidase (EPO). The reactions inhibited include iodination in the presence and absence of chloride and the oxidation of guaiacol. Iodination by MPO and H2O2 is stimulated by chloride due to the intermediate formation of hypochlorous acid (HOCl). Iodination by reagent HOCl also is inhibited by deferoxamine with the associated consumption of HOCl. Iron saturation of deferoxamine significantly decreased but did not abolish its inhibitory effect on iodination by MPO + H2O2 or HOCl. Deferoxamine did not affect the absorption spectrum of MPO, suggesting that it does not react with or remove the heme iron. The conversion of MPO to Compound II by H2O2 was not seen when H2O2 was added to MPO in the presence of deferoxamine, suggesting either that deferoxamine inhibited the formation of Compound II by acting as an electron donor for MPO Compound I or that deferoxamine immediately reduced the Compound II formed. Iodination by stimulated neutrophils also was inhibited by deferoxamine, suggesting an effect on peroxidase-catalyzed reactions in intact cells. Thus deferoxamine has multiple effects on the formation and activity of phagocyte-derived oxidants and therefore its inhibitory effect on oxidant-dependent damage needs to be interpreted with caution.
吞噬细胞可产生超氧化物(O₂⁻.)和过氧化氢(H₂O₂),有人提出它们在铁催化反应中相互作用形成羟基自由基(OH.)(哈伯 - 韦斯反应)。去铁胺能螯合呈催化无活性形式的铁,因此去铁胺的抑制作用被用作哈伯 - 韦斯反应产生的OH.参与反应的证据。我们在此报告,去铁胺还能抑制吞噬细胞过氧化物酶催化的反应,即髓过氧化物酶(MPO)和嗜酸性粒细胞过氧化物酶(EPO)。被抑制的反应包括在有和没有氯离子存在时的碘化反应以及愈创木酚的氧化反应。由于次氯酸(HOCl)的中间形成,氯离子会刺激MPO和H₂O₂引发的碘化反应。试剂HOCl引发的碘化反应也会被去铁胺抑制,同时伴有HOCl的消耗。去铁胺的铁饱和显著降低但并未消除其对MPO + H₂O₂或HOCl引发的碘化反应的抑制作用。去铁胺不影响MPO的吸收光谱,表明它不与血红素铁反应或去除血红素铁。当在去铁胺存在的情况下向MPO中加入H₂O₂时,未观察到MPO转化为化合物II,这表明要么去铁胺通过作为MPO化合物I的电子供体来抑制化合物II的形成,要么去铁胺立即还原了形成的化合物II。去铁胺也抑制了受刺激的中性粒细胞的碘化反应,表明其对完整细胞中过氧化物酶催化的反应有影响。因此,去铁胺对吞噬细胞衍生氧化剂的形成和活性有多种作用,所以其对氧化依赖损伤的抑制作用需要谨慎解读。